Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

PDZ Binding Kinase (PBK) - a Novel Gene Driving Genomic Evolution in Multiple Myeloma

Subodh Kumar, PhD, Leutz Buon, Srikanth Talluri, PhD, Jialan Shi, MD PhD, Hervé Avet-Loiseau, MD PhD, Mehmet Kemal Samur, PhD, Masood A. Shammas, PhD, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 4474.

https://doi.org/10.1182/blood-2018-99-119186

Published: 2018

Journal Articles

Combining Next Generation Proteomics Platforms with Drug Sensitivity Resistance Testing AllowsÂ Identification of Physiologically Distinct Sub-ClonesÂ That Can Inform Therapeutic and Drug Development Strategies

Despina Bazou, BSc, MSc, PhD, Muntasir M Majumder, MSc, BPharm, Ciara Tierney, BSc, Sinead O'Rourke, BSc, Pekka Anttila, MD, Raija Helena Silvennoinen, MD PhD, Caroline A Heckman, PhD, Paul Dowling, BSc, PhD, Peter O'Gorman, MD PhD FRCP, FRCPath

Blood (2018) 132 (Supplement 1): 1901.

https://doi.org/10.1182/blood-2018-99-115910

Published: 2018

Journal Articles

Characteristics and Potential Biomarkers of Adult Sickle Cell Patients with Chronic Pain

Camila Albo, Sanjiv Kumar, PhD, Michael Pope, Bachelors/MDcal Student, Kyle Michael Kidwell, Bachelors/MDcal Student, Niren Patel, MBBS, Leigh Wells, MSN, Latanya Bowman, RN, Nadine Barrett, MSN, Xu Hongyan, PhD, Abdullah Kutlar, MD

Blood (2018) 132 (Supplement 1): 857.

https://doi.org/10.1182/blood-2018-99-115084

Published: 2018

Journal Articles

DNA Demethylating Agents Generate a Brcaness Effect in Multiple Sporadic Tumor Types: Prediction for Sensitivity to PARP Inhibitors in AML

Aksinija A Kogan, BS, MS, Lena J Mclaughlin, BS, Michael Topper, BS, Nidal Muvarak, PhD, Lora Stojanovic, BS, T Michael Creed, BS, MS, Soren Bentzen, PhD DMSc, Curt I. Civin, MD, Maria R. Baer, MD, Tami J Kingsbury, PhD, Stephen Baylin, MD, Feyruz V. Rassool, BSc, PhD

Blood (2017) 130 (Supplement 1): 3347.

https://doi.org/10.1182/blood.V130.Suppl_1.3347.3347

Published: 2017

Journal Articles

Prevalence of Bone Marrow Fibrosis in 47 Cases of Autoimmune Hemolytic Anemia Patients: Clinical and Biologic Relationships

Bruno Fattizzo, MD, Anna Zaninoni, BS, Umberto Gianelli, Alberto Zanella, MD, Agostino Cortelezzi, Prof, Wilma Barcellini, MD

Blood (2017) 130 (Supplement 1): 3491.

https://doi.org/10.1182/blood.V130.Suppl_1.3491.3491

Published: 2017

Journal Articles

PSMB9 Mediates Resistance to Bortezomib in Multiple Myeloma

Aneel Paulus, MD, Sharoon Akhtar, MPhil, Thomas Caulfield, Alak Manna, PhD, Vivek Roy, MD, Sikander Ailawadhi, Asher A. Chanan-Khan, MD

Blood (2017) 130 (Supplement 1): 3836.

https://doi.org/10.1182/blood.V130.Suppl_1.3836.3836

Published: 2017

Journal Articles

SET8 Is a Potential Therapeutic Target in MM

Herviou Laurie, Fanny Izard, Elke De Bruyne, PhD, Eva Desmedt, Anqi Ma, PhD, Jian Jin, PhD, Karin Vanderkerken, PhD, Eric Julien, Jerome Moreaux, PhD

Blood (2016) 128 (22): 4435.

https://doi.org/10.1182/blood.V128.22.4435.4435

Published: 2016

Journal Articles

Lomeguatrib, a O 6 -Methylguanine-DNA-Methyltransferase (MGMT) Inhibitor, Induces DNA Damage Induced Apoptosis By Targeting Double-Strand DNA Repair in Multiple Myeloma

Dilara Akcora Yildiz, PhD, Tulin Ozkan, PhD, Yunus Yukselten, MS, Nezaket Turkel Sesli, PhD, Seyma Ozkanca, MS, Mehmet Gunduz, MD, Mehmet Ozen, MD, Meral Beksac, MD, Asuman Sunguroglu, PhD

Blood (2016) 128 (22): 2103.

https://doi.org/10.1182/blood.V128.22.2103.2103

Published: 2016

Journal Articles

Flap Structure-Specific Endonuclease 1 (FEN1) May be a Key Mediator of Genome Instability in Myeloma: A Cellular Vulnerability with Potential Therapeutic Significance

Masood A Shammas, PhD, Leutz Buon, Subodh Kumar, PhD, Mehmet K. Samur, PhD, David Alagpulinsa, PhD, Purushothama Nanjappa, Nikhil C Munshi, MD

Blood (2016) 128 (22): 4440.

https://doi.org/10.1182/blood.V128.22.4440.4440

Published: 2016

Journal Articles

TET2 Downregulation Leads to AML Cells Sensitive to Decitabine

Qingxiao Chen, M.MD, Jingsong He, PhD, Xing Guo, M.MD, Jing Chen, M.MD, Li Yang, PhD, Xuanru Lin, M.MD, Yi Li, PhD, Enfan Zhang, M.MD, Yang Yang, PhD, Wenjun Wu, MD, Donghua He, PhD, He Huang, MD PhD, Shizhou Liu, MD PhD, Zhen Cai, MD PhD

Blood (2015) 126 (23): 3643.

https://doi.org/10.1182/blood.V126.23.3643.3643

Published: 2015

Journal Articles

Nitric Oxide As a Mediator of Bone Marrow Fibrosis in Patients with Myelofibrosis

Ali Tabarroki, MD, Daniel Lindner, MD PhD, Valeria Visconte, PhD, Nikolaos Papandantonakis, Jing Ai, MD PhD, Mikkael A. Sekeres, MD MS, Anjali S. Advani, MD, Matt E. Kalaycio, MD, Tracy Cinalli, RN, Kristin Colaluca, RN, Gina Rupp, John Desamito, Heesun J. Rogers, MD PhD, Ramon V. Tiu, MD

Blood (2014) 124 (21): 4587.

https://doi.org/10.1182/blood.V124.21.4587.4587

Published: 2014

Journal Articles

Autoimmune Myelofibrosis (AIMF) – Clinical Features, Course and Outcome

Caroline Irene Piatek, M.D., Maria E. Vergara-Lluri, M.D., Vinod Pullarkat, MD, Imran N. Siddiqi, M.D, Ph.D., Casey O'Connell, MD, Donald I. Feinstein, MD, Russell K. Brynes, MD

Blood (2013) 122 (21): 3714.

https://doi.org/10.1182/blood.V122.21.3714.3714

Published: 2013

Journal Articles

AML1-ETO Inhibits DNA Repair Pathways and Promotes the Accumulation of DNA Damage and the Activation of p53.

Ondrej Krejci, MD, PhD, Mark Wunderlich, Junping Wei, MD, PhD, Paul R. Andreassen, PhD, Thomas X. Lu, James C. Mulloy, PhD

Blood (2006) 108 (11): 1412.

https://doi.org/10.1182/blood.V108.11.1412.1412

Published: 2006

Journal Articles

Expression of Proliferation Related Genes in Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) Patients with Resistance to Low Dose Vidaza and Thalidomide.

Naomi Galili, PhD, Benjamin L. Ebert, MD,PhD, Peter Westervelt, MD, Jessica Wasserman, Daniel Lee, MD, Fatima Z. Raza, MD, Todd R. Golub, MD, Azra Raza, MD

Blood (2006) 108 (11): 2658.

https://doi.org/10.1182/blood.V108.11.2658.2658

Published: 2006

Journal Articles

Gene Expression Pathways That Distinguish Diagnosis and Relapse in Childhood Acute Lymphoblastic Leukemia.

Deepa Bhojwani, MD, Elizabeth Raetz, MD, Naomi Moskowitz, MD, Hokyung Lee, Bret Sohn, Stephen P. Hunger, MD, William L. Carroll, MD

Blood (2005) 106 (11): 848.

https://doi.org/10.1182/blood.V106.11.848.848

Published: 2005

Journal Articles

Cloning and Characterization of a Tipifarnib-Resistant BCR/ABL-Positive Cell Line, K562/RR.

Takuji Miyoshi, MD, Tadashi Nagai, MD, Ken Ohmine, MD, Satoru Kikuchi, MD, Makiko Nakamura, B.Agr, Keiya Ozawa, MD

Blood (2005) 106 (11): 1527.

https://doi.org/10.1182/blood.V106.11.1527.1527

Published: 2005

Journal Articles

Reduced-Intensity Unrelated Cord Blood Transplantation (RICBT) for Myelofibrosis (MF).

Shinsuke Takagi, MD, Shigesaburo Miyakoshi, MD, PhD, Yasunori Oota, MD, Daisuke Kato, MD, Tomomi Kawano, MD, Eiji Kusumi, MD, Tomoko Matsumura, MD, PhD, Koichiro Yuji, MD, PhD, Naoyuki Uchida, MD, PhD, Kazuhiro Masuoka, MD, PhD, Atsushi Wake, MD, PhD, Akiko Yoneyama, MD, PhD, Shuichi Taniguchi, MD, PhD

Blood (2005) 106 (11): 5437.

https://doi.org/10.1182/blood.V106.11.5437.5437

Published: 2005

NARROW

PDZ Binding Kinase (PBK) - a Novel Gene Driving Genomic Evolution in Multiple Myeloma

Combining Next Generation Proteomics Platforms with Drug Sensitivity Resistance Testing AllowsÂ Identification of Physiologically Distinct Sub-ClonesÂ That Can Inform Therapeutic and Drug Development Strategies

Characteristics and Potential Biomarkers of Adult Sickle Cell Patients with Chronic Pain

DNA Demethylating Agents Generate a Brcaness Effect in Multiple Sporadic Tumor Types: Prediction for Sensitivity to PARP Inhibitors in AML

Prevalence of Bone Marrow Fibrosis in 47 Cases of Autoimmune Hemolytic Anemia Patients: Clinical and Biologic Relationships

PSMB9 Mediates Resistance to Bortezomib in Multiple Myeloma

SET8 Is a Potential Therapeutic Target in MM

Lomeguatrib, a O 6 -Methylguanine-DNA-Methyltransferase (MGMT) Inhibitor, Induces DNA Damage Induced Apoptosis By Targeting Double-Strand DNA Repair in Multiple Myeloma

Flap Structure-Specific Endonuclease 1 (FEN1) May be a Key Mediator of Genome Instability in Myeloma: A Cellular Vulnerability with Potential Therapeutic Significance

TET2 Downregulation Leads to AML Cells Sensitive to Decitabine

Nitric Oxide As a Mediator of Bone Marrow Fibrosis in Patients with Myelofibrosis

Autoimmune Myelofibrosis (AIMF) – Clinical Features, Course and Outcome

AML1-ETO Inhibits DNA Repair Pathways and Promotes the Accumulation of DNA Damage and the Activation of p53.

Expression of Proliferation Related Genes in Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) Patients with Resistance to Low Dose Vidaza and Thalidomide.

Gene Expression Pathways That Distinguish Diagnosis and Relapse in Childhood Acute Lymphoblastic Leukemia.

Cloning and Characterization of a Tipifarnib-Resistant BCR/ABL-Positive Cell Line, K562/RR.

Reduced-Intensity Unrelated Cord Blood Transplantation (RICBT) for Myelofibrosis (MF).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only